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Identity 
Other names: IMD2, SCNX, THC, THC1, WASP 




The WAS gene has been mapped to the region 
Xp11.22-Xp11.3.  
It has 12 exons spanning 9 kb of genomic DNA. 
Protein 
Description 
502 amino acids; 54 kDa; consists of an N-terminal 
Ena-VASP homology domain 1 (EVH1), a basic 
domain, a GTPase binding domain (GBD), 
polyproline domain and the C-terminal domain 
comprising of a cluster of verprolin homology (V), 
central (C) and acidic regions (A) (the VCA domain). 
Expression 
WASP is consitutively expressed in all 
haematopoietic stem-cell-derived lineages, except in 
mature red blood cells.  
Neural WASP (N-WASP) and WASP family 
verprolin homologous protein 1 (WAVE1), WAVE2 
and WAVE3 are more widely expressed. 
Localisation 
WASP is located in the cytoplasmic compartment 
with highest density along the cell membrane. 
Function 
WASP family members function as scaffold proteins, 
transducing a wide range of signals from proteins or 
membranes to mediate dynamic changes in the actin 
cytoskeleton. A lack of WASP results in cytoskeletal 
defects that compromise multiple aspects of normal 
cellular activity including proliferation, phagocytosis, 
immune synapse formation, adhesion and directed 
migration. 
WASP function in Haematopoietic system 
WASP is expressed by all leukocytes, but dependence 
on WASP for homeostatic regulation varies with cell 
lineage and stage of maturity. WASP is required for 
the development and survival of mature lymphoid 
cell lineages but myeloid cell lineages that express 
normal WASP levels show little or no selective 
advantage. 
WASP function in T cells 
T cell development appears normal in WAS patients 
but the circulating lymphocyte number is reduced and 
progressively declines throughout childhood. There is 
decreased thymic output and lowered peripheral T 
cell survival rates. T cell proliferation in response to 
TCR stimulation is defective in vitro, and the clonal 
distribution of TCR β -chain families is usually 
disturbed. 
The morphology of WASP-deficient T cells is 
disturbed with fewer microvillus-like surface 
projections. They are less able to proliferate in 
response to various stimuli because WASP is 
normally recruited to the immunological synapse. In 
the absence of WASP, the localised assembly of 
filamentous actin and recruitment of other 
immunological synapse proteins is impaired in 
response to TCR stimulation. 
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Figure 1: WASP and lymphocyte homeostasis. Dependence on WASP for homeostatic regulation varies with cell lineage and 
stage of maturity. Early stages of B cell development proceed normally in the bone marrow but homeostatic defects of peripheral 
subpopulations are apparent. The same is true for peripheral T-cells; and in humans with revertant WASP expression confers a 
survival advantage to these populations. Picture courtesy of Dr Siobhan Burns. 
 
WASP function in B cells 
WASP-deficient B cells have defective polarisation, 
spreading, aggregation and migration in response to 
CXCL13. Marginal Zone B cells are reduced and 
they fail to migrate in response to sphingosine-1-
phosphate, which is crucial for marginal zone 
homing. This is consistent with a defect in response 
to polysaccharide antigens. The abnormal regulation 
of the actin cytoskeleton in B cells may be important 
for development of autoimmunity. 
WASP function in NK cells 
In the absence of WASP, NK cell cytotoxicity is 
impaired as immune synapse formation relies upon 
actin polymerisation. There is also defective signal 
transduction and poor intercellular interactions, 
particularly with dendritic cells. 
WASP function in Invariant NKT cells 
Invariant NKT (iNKT) cells express both NK- and T-
cell receptors; and recognise lipid antigens via the 
non-classical class I MHC molecule CD1d. They are 
thought to be important in initial response to 
infection, protection from autoimmunity and 
clearance of malignant cells. WAS patients have 
reduced numbers of iNKT cells which also secrete 
less cytokine when stimulated. 
WASP function in innate immune cells 
WASP-deficient myeloid lineage cells have impaired 
phagocytosis, a process which relies upon quick and 
regulated de novo actin polymerisation. In addition, 
monocytes, macrophages, DCs and osteoclasts lack 
ability to assemble podosomes in the absence of 
WASP, resulting in severe defects in adhesion and 
motility.  
Efficient cell migration also requires interactions 
involving integrins. In WASP-deficient human and 
mouse neutrophils, β2 integrin clustering is defective 
resulting in impaired integrin-dependent functions 
that range from adhesion and migration to 
degranulation and activation of the respiratory burst. 
Autoimmunity 
Abnormal Treg have been implicated in the onset of 
autoimmunity in WAS. WASP-deficient Treg cells fail 
to proliferate normally in response to TCR simulation 
and their suppressive activity is impaired in vitro.  
Dysregulation of B cell tolerance is supported by the 
presence of autoantibodies in WAS patients and in 
both WASP null and phosphorylation mutant mice. 
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Figure 2: WASP protein function in immune cells. WASP is important in regulating the polymerisation of new branched actin 
filaments and has a role in processes such as phagocytosis, cell motility and signalling. BCR, B cell receptor; NK, natural killer; TCR, 




More than 295 unique mutations have been identified. 
158 unique WASP gene mutations had been 
identified in a cohort of 270 unrelated WAS/XLT 
families.  
The most common are missense mutations, followed 
by splice-site mutations, short deletions, and 
nonsense mutations.  
Insertions, complex mutations, and large deletions are 
less frequent.  
Most deletions and insertions involve fewer than 10 
nucleotides and result in frame shifting and early 
termination of transcription. 
Amino acid substitutions are typically located in 
exons 1-4.  
Splice-site mutations occur predominantly in the 
downstream half of the WASP gene (introns 6-12). 
Mutations affecting invariant splice sites may result 
in multiple splicing products, which often include 
small amounts of normal WASP cDNA. 
Six mutational hotspots, defined as occurring in > 
2,5% of the population, have been identified.  
Three of these hotspots represent point mutations 
within the coding regions, whereas the other 3 
involve splice sites. 
Somatic 
Patients who have missense or splice-site mutations 
may have residual protein expression and have a less 
severe clinical phenotype. 
Implicated in 
Note 
Mutations of the WASP gene result in 3 distinct 
phenotypes: Wiskott-Aldrich Syndrome (WAS), X-
linked thrombocytopaenia (XLT), and congenital X-
linked neutropaenia (XLN). 
Wiskott- Aldrich syndrome (WAS) 
Note 
WAS is characterised by low numbers of small 
platelets, easy bruising and prolonged bleeding, 
eczema and recurrent infections.  
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It can be complicated by autoimmunity and 
haematopoietic cell malignancies. 
Prognosis 
Classical WAS has a poor prognosis, but early 
treatment with haematopoietic stem cell transplant is 
curative in most patients. Reported median survival in 
patient with WAS is age 20 years. Death results from 
infections, bleeding complications, autoimmune 
diseases, and malignancies. WAS-associated 
malignancies have a poor prognosis. 
Cytogenetics 
Mutations of the WASP gene that result in absent or 
truncated protein are more likely to give rise to the 
classic WAS phenotype.  
Three of the six hotspot mutations identified 
(665C>T, IVS8+1 g>n and IVS8+1 to +6 del gtga) 
have been found to be predominantly WASP-negative 
and have a high clinical score characteristic for WAS. 
Oncogenesis 
Malignancies are more frequent in adolescents and 
young adults with the classic WAS phenotype. Most 
frequent malignancies reported are B cell lymphoma 
(often Epstein-Barr virus-positive) and leukaemia. 
Some younger patients may also present with marrow 
dysplasia. 
X-linked thrombocytopaenia (XLT) 
Note 
A milder clinical variant with fewer problems with 
eczema and minimal immunological disturbances. 
Incidence of autoimmune disease is less in XLT but 
has been reported to occur. 
Prognosis 
XLT patients generally have a benign disease course 
and excellent long-term survival, but they still carry 
an increased risk for severe disease-related events 
such as life-threatening infection (especially post 
splenectomy), severe bleeding, or autoimmunity and 
cancer. 
Cytogenetics 
The XLT phenotype is generally those with missense 
or splice-site mutations that allow expression of 
normal-sized mutated protein, often in reduced 
quantity.  
Three of the six hotspot mutations (168C>T; 290 
C>N/291 G>N and IVS6+5g>a) have been found 
consistently in WASP-positive patients. 
Oncogenesis 
The incidence of malignancies in patients of the XLT 
phenotype is increased, but is lower than that in 
classic WAS. 
X-linked neutropaenia (XLN) 
Note 
A clinically and biologically distinct WASP-
associated disorder, results from presence of a cluster 
of mutations that confer constitutive WASP 
activation. These mutations have been found to lead 
to genetic instability through dysregulation of actin 
polymerisation. Main clinical symptom is 
neutropaenia which causes a predisposition to 
bacterial infection, as well as myelodysplasia and 
other cytopaenias. 
Cytogenetics 
Only four mutations (Leu270Pro, Ser270Pro, 
Ile276Ser and Ile294Thr) have been reported so far. 
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